Ask AI
Non–Cystic Fibrosis Bronchiectasis the Road to Victory

CE / CME

The Road to Victory Over the Vortex: Innovations in Non–Cystic Fibrosis Bronchiectasis

Physician Assistants/Physician Associates: 1.00 AAPA Category 1 CME credit

Nurse Practitioners/Nurses: 1.00 Nursing contact hour

Pharmacists: 1.00 contact hour (0.1 CEUs)

Physicians: maximum of 1.00 AMA PRA Category 1 Credit

Released: June 26, 2025

Expiration: June 25, 2026

Pretest

Progress
1 2 3
Course Completed
Please answer the questions below.
1.

How confident are you in your ability to educate patients about the disease process, prognosis, and treatment options for NCFBE?

2.

A 65-yr-old patient with NCFBE and chronic P aeruginosa infection has frequent exacerbations despite guideline-directed therapy, including long-term macrolide use and airway clearance. Based on results from the ASPEN trial, which of the following best characterizes the effect of brensocatib in patients like this?

3.

A 72-yr-old patient with NCFBE has ≥3 exacerbations this yr, chronic P aeruginosa infection, elevated neutrophil elastase, and worsening bronchiectasis on imaging. The patient is on inhaled antibiotics and adherent to airway clearance; eosinophils are normal. Which next step best aligns with the patient's treatable traits and disease mechanisms?